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Summary. In the past twenty years, molecular genetics has created powerful tools for genetic manipulation of living 
organisms. Whole genome sequencing has provided necessary information to assess knowledge on gene function and protein 
networks. In addition, new tools permit to modify organisms to perform desired tasks. Gene function analysis is speed up by 
novel approaches that couple both high throughput data generation and mining. Synthetic biology is an emerging field that uses 
tools for generating novel gene networks, whole genome synthesis and engineering. New applications in biotechnological, 
pharmaceutical and biomedical research are envisioned for synthetic biology. In recent years these new strategies have opened 
up the possibilities to study gene and genome editing, creation of novel tools for functional studies in virus, parasites and patho-
genic bacteria. There is also the possibility to re-design organisms to generate vaccine subunits or produce new pharmaceuticals 
to combat multi-drug resistant pathogens. In this review we provide our opinion on the applicability of synthetic biology strat-
egies for functional studies of pathogenic organisms and some applications such as genome editing and gene network studies 
to further comprehend virulence factors and determinants in pathogenic organisms. We also discuss what we consider important 
ethical issues for this field of molecular biology, especially for potential misuse of the new technologies. [Int Microbiol 2015; 
18(2):71-84]
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“Defining” life
What is life? This fundamental question has intrigued scien-
tists for centuries and a strong definition is needed in order to 
understand life and all its manifestations. What are the univer-
sal constituents that make a living organism alive? This ques-
tion is also complicated to give a compelling answer since not 
all the components, dynamics and interactions inside a living 
organism are well understood and the relationship among 
them are also difficult to assess [6]. At first, life has been de-
fined as an entity that is capable of passing on genetic infor-
mation and is subjected to diverse environmental selective 
pressures that ensure diversity, but a more appropriate defini-
tion considers the following: “Life (a living individual) is a 
self-sustaining object belonging to a set of elements capable 
of undergoing Darwinian evolution” [10]. 
In the case of pathogenic organisms, this definition also 
involves the host and the selective pressures that affect both 
organisms. With the “omic” approach we are one step closer 
to answer this fundamental biological, philosophical question 
since we can tackle the limitation of the population diversity 
found in all living organisms and also gain knowledge on the 
constituents and the interactions they undergo. However, or-
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ganisms—even those with small genomes—are too complex 
to characterize and understand all the biological processes 
they carry out under different conditions. New technologies 
are bringing us closer to achieve the goal of understanding 
how living organisms work and evolve, which in turn may 
also lead us in the right path to fight pathogens. As presented 
in Fig. 1 some major technological advances and their appli-
cations may help basic and applied research to clarify the 
most important aspects of pathogenicity and bring about new 
strategies to fight pathogens. One important step towards un-
derstanding pathogenesis is to understand the genes and fac-
tors required from both pathogen and host. 
“Reading” DNA 
The discovery of DNA structure has been a major advance to 
understand the molecular basis of heredity [13]. With that dis-
covery, molecular genetics was born and made it possible to 
study both gene function and the molecular basis of develop-
ment and disease, which ultimately led to modern biotechnol-
ogy and genetic engineering. Understanding DNA structure 
allowed researchers to assess sequencing methods or the abil-
ity to “read” DNA that was important to uncover the diversity 
of life, evolution and taxonomy. Several DNA technologies 
including cloning, the polymerase chain reaction (PCR), se-
quencing, next-generation sequencing (NGS) and more re-
cently synthetic biology have broadened our capabilities to 
study organisms [11,45].
The tools of genomic biology are the most effective ana-
lytical tools to determine the gene structure and content of any 
given organism. Unfortunately, they tells us nothing about 
gene function and protein networks. However, this is the most 
fundamental basis for assessing knowledge on gene function 
and, without it, synthetic biology loses its most fundamental 
tool. 
Up to June 2015, 58,150 organisms have been sequenced 
that comprise 1,037 Archaea, 44,576 Bacteria and 8,181 Eu-
karya. In addition, GenBank contains data from 300,000 for-
mally described species in the form of expressed sequence tag 
(EST), genome survey sequence (GSS) and whole-genome 
shotgun sequence (WGS) [7]. All these data are the basis for 
for the study of all model organisms. Having its genome se-
quenced, research on a given organism can be boosted to find 
out all gene functions and to develop new tools for manipulat-
ing it. This information can open up discovery of gene net-
works that provide us with comprehensive data for mining 
essential genes for particular biological functions.
The exponential growth of genome projects is explained 
in the reduction of costs (the first human genome project costs 
were around 2,700 millon US dollars, while currently it costs 







Fig. 1. Time line for the development of synthetic biology.
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be afforded even by medium and small-sized laboratories, 
where data are required for antibacterial molecule research, 
vaccine development, diagnostics and epidemiology research 
[33].
The first genomes that were sequenced were confined to 
large consortia and a considerable amount of resources to 
achieve the full genome sequence and annotation was re-
quired. The first organism fully sequenced and annotated was 
Haemophilus influenza, a highly relevant human pathogen 
[22]. The genomes of Escherichia coli and Saccharomyces 
cerevisiae, which are the most extensively studied organisms, 
were both published in 1997 (Fig. 1). Refinement of sequenc-
ing and analytical tools to generate faster and more accurate 
sequences have been developed since then. With NGS tech-
nologies, whole genome data can be quickly generated and 
applied to different biological questions such as total RNA 
sequencing, which gives more information than microarray 
data on abundance, half-life and processing of RNA, genome 
sequencing and enriched pools of environmentally adquired 
DNA samples [39].
As it is discussed latter, microbial diversity has been un-
cover using these powerful techniques and more questions 
than answers have arisen from all the data generated. Genom-
ics has been modified extensively, from Sanger sequencing 
methods to micro-reactor sequencing and single cell genom-
ics, and it has become of great importance to study patho-
genic organisms. Even though most of the information that 
we can gather on microbial populations come from classical 
microbiological studies, now it is possible to determine at 
broad scale the microbial populations present in a sample and 
their dynamics. One such example is the city-scale metage-
nomics survey undertaken by Afshinnekoo and colleagues by 
which several pathogen distributions, antibiotic resistance 
and large scale new organism identification was assessed and 
correlated to environmental, geographical distribution and 
even human associated genomic data [2]. Full genome se-
quencing and annotation also speeds up the research for iden-
tifying essential and virulence-related genes present in a given 
population or sample (see [24] for some review examples that 
illustrate this matter). 
Uncovering microbes through genomics
Evidence on genomic dynamics and evolution provides part 
of the answer to life’s diversity. Once an organism genome is 
fully sequenced, knowledge and research on the biological 
function of each gene is speed up and therefore more knowl-
edge is gained from functional studies and genome data min-
ing. Since the establishment of public genome databases and 
standard criteria for genomic data storage and mining, the 
amount of genomic, metagenomic and pangenomic data has 
increased rapidly [21]. The standards set for genomic data 
created by the Genomic Standards Consortium considered the 
following: standards for new genomic data, methods for stor-
ing and sharing the data generated and harmonization of the 
information so that the scientific community can easily access 
it [21]. The value of genomic data can be exemplified with the 
need to achieve rapid comparison between isolates (both by 
standard microbiological methods or whole sample sequenc-
ing), especially during epidemic conditions. Data accession is 
uniformed using sequence identifiers, and databases are linked 
together in order to keep information available, protected, cu-
rated and up to date [7]. 
The use of whole genome sequencing have opened up the 
field of evolutionary and population genomics, which allows 
to characterize population structure and dynamics, and to 
know what factors affect the population in certain environ-
ments [18]. In pathogenic organisms, this is of outmost im-
portance. Recent efforts have shed light into the factors that 
modulate pathogenicity. Epidemiology can be studied in 
much depth since data from whole genome sequencing can 
inform the pattern of pathogenicity displayed by an outbreak, 
resistance to antibiotics, virulence and persistence factors. 
Also, information about mobile genetic elements, horizontal 
gene transfer and adaptation features can be uncovered. Such 
information can be obtained not only as a general or represen-
tative sample, but also at the “local” level, such as in the event 
of a recurrent or emergency outbreak, contaminated sources 
or even at the level of hospital related infections [15]. Other 
aspects of microbial life have been revealed by genomic biol-
ogy.
We are facing the “dark matter” of microbial life. This 
considers all those organisms and even divisions that have 
eluded isolation and characterization under laboratory condi-
tions. McLean and collaborators showed that a “mini-metage-
nome” could be generated from rare events. The authors se-
quenced whole genomes from single cells isolated by flow 
cytometry (again, converging many techniques for new pur-
poses) from a sink in a hospital restroom [46]. This type of 
work leads research in a different direction: single cell ge-
nomics. In this particular study, tackling the heterogeneity of 
samples (sequence itself or G+C content) as well as contami-
nants is cumbersome. But with the implementation of novel 
computational toolsfaster and more accurate sequencing 
methods could be developed. Once the genome of an organ-
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ism has been fully sequenced, the next step is to analyze it in 
order to obtain useful information. The study of pathogenesis 
and host-pathogen interactions has been favored by genom-
ics.
In the case of virulence related genes it can be compli-
cated to be certain of their specific role. Even defining viru-
lence is not easy. It is often defined as the capability to dam-
age or harm the host when invaded by a pathogen, but this 
definition does not consider the role of other factors that are 
important for survival within the host. Genomics provides the 
challenge when there is a dramatic increase in host damage or 
spreading or when pathogens shift to infect new host species 
(such as SARS or Ebola virus), resulting in new and devastat-
ing outbreaks and epidemics. The use of high throughput se-
quencing methods, can allow to define natural reservoirs of 
deadly pathogens, ecological interactions and perhaps to un-
derstand several of their pathogenesis mechanisms and how 
disease evolves. Sequencing environmental samples, such as 
pan enome sequencing projects, have revealed the true micro-
bial diversity that is making evident also the real landscape of 
pathogen–epidemiology–persistence. Hand in hand, this also 
may lead to important health-related discoveries for antibiotic 
resistance and pathogenicity statistics near real-time.
Microbiomes and health
Disease is also related to our own microorganisms. Recently 
new sequencing techniques have revealed that humans hold 
an immense universe inside, which modulates many biologi-
cal functions. Research efforts concentrate to achieve the 
power of all the living organisms inside the body to promote 
immune boost, vaccine delivery systems and keeping a safe 
environment for beneficial microorganisms. We now have 
knowledge on some effects of the microbiota present in ver-
tebrates; one such example is the effect on circadian clock 
disturbances as reported by Thaiss and collaborators [59]. But 
how farther can we go? From environmental genome se-
quencing we learned that emerging pathogens are lurking that 
can potentially infect humans. One example is the enigmatic 
chlorovirus ATCV that usually infects algae but also can 
cause changes in cognitive functions in humans and mice 
[69].
The human microbiome plays a major role in health and 
disease and its actual composition is variable for each indi-
vidual. Gut microbes have been proposed to regulate behav-
ior and social skills needed for the bacteria to colonize other 
individuals. The Human Microbiome Project has two impor-
tant goals; study the composition of healthy individuals and to 
understand the effect of changes during disease. Also, this 
project bypassed the limitation of cultivating and character-
izing the microbial communities in samples from patients or 
experimental animals. NGS have provided a glimpse on the 
composition profile of normal intestinal microbiome and 
opened the possibility of treating certain disorders in patients. 
The Human Microbiome Project is a good example of how 
modern science should thrive, as a collaborative and multidis-
ciplinary effort. In a future, with the available data on the 
host’s microbial DNA and transcriptome, we will be able to 
predict the metabolic capacity of the bacteria present in the 
host and measure its impact on health besides the host life-
style and environmental stress [62]. 
With novel bioinformatic and statistical tools, identifying 
dysbioses (changes in the normal microbiota content) be-
comes easier with the possibility of developing new treat-
ments for diseases such as chronic inflammatory bowel dis-
ease instead of using fecal transplant on patients [67]. Analy-
ses that identify perturbations in molecules related to disease 
can be used to interpret their physiological role, interaction 
with truly pathogenic organisms or integrate sequence data 
with whole-community relationships.
New technologies are not problem-free and require trou-
bleshooting. One good example is the amount of false posi-
tive organisms present in samples and library preparation, for 
example in ancient pathogen identification (which is a prob-
lem in any given sample), can give false diagnostics and pop-
ulation content biases. NGS requires stringent cleaning mea-
surements and laboratory reagent preparations in order to 
avoid cross contamination and misleading results, especially 
with rare samples [53].
Technology and human wit have designed novel ap-
proaches to answer complex biological questions and prob-
lems, for instance, how many organisms are present in dust 
and airborne microbial communities [71]. This particular 
question poses a major problem of low biological sample 
content and avoids growth to eliminate biased conclusions. 
Integrating engineering for designing and applying special-
ized apparatus for sample collection, enrichment and analy-
sis, and novel computer algorithms to assemble and analyze 
data, provides an image of microbes present in air samples. 
All this major technical advances are needed only to read 
DNA properly and then make some sense out of all that infor-
mation. There are remaining questions about environmental 
samples, such as how many bacteria are metabolically active, 
capable of division and the cycles between population densi-
ties. 
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Understanding the genome 
“Data does not equal information; information does not equal 
knowledge; and, most importantly of all, knowledge does not 
equal wisdom. We have oceans of data, rivers of information, 
small puddles of knowledge, and the odd drop of wisdom.” 
Henry Nix made this statement in his keynote address (A Na-
tional Geographic Information System–An achievable objec-
tive?) to the Australasian Urban and Regional Information 
Systems Association in 1990) [32]. In fact, gathering tera-
bytes of data does not mean givung them some sense or fully 
understand them. Figures 2 and 3 show some applications that 
data so far gathered can have in different fields. High-through-
put analyses that have been carried out so far for genome, 
transcriptome and proteome assays, have provided more data 
that we can handle and make sense of it. Most of the research 
in ‘omics’ is now done by molecular biologists, biochemists, 
mathematicians, physicists and computer experts, and the 
main reason for pluridisciplinarity is to find useful informa-
tion and search for patterns in all that data. 
Genomic data tell us which and how many genes are pres-
ent in any organism’s genome, but cannot tell neither the 
function of all them nor the roles of protein networks, which 
requires specific experimental data. Moreover, gene structure 
and G+C contents are quite different between bacteria and eu-
karyotic organisms, so the algorithms for analysis must take 
into account different approaches for mining data, for exam-
ple for generating comprehensive data for regulatory net-
works or genome analysis and annotation. With massive ge-
nome data, it is also possible to know some of the evolution-
ary relationships between organisms and the influence of the 
environment on genome structure, regulation and diversity 







Fig. 2. Basic and applied research areas that synthetic biology has important influence. 
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tance, since the lifestyle of each organism modulates the ge-
nomic landscape and protein effector machineries that give 
rise to the phenotypes of pathogenic organisms (Figs. 2 and 
3). In addition, interactions between the microbiome and host 
cells can remodel the genomic landscape in pathogens. Even 
with the most powerful computers and algorithms available, 
genetic sequence only tells half the story behind the physiol-
ogy of the organism and the possible roles of the protein net-
works that it can use at a given point of its life cycle,. Most 
useful data are represented by well-known genes, but it is not 
possible to make sense of unknown open reading frames.
Two examples lead us to reformulate life and the dynamics 
that render diversity. These two examples can further increase 
our knowledge on gene and protein networks. The first one 
was developed by Suzuki and collaborators [58]. Using a nov-
el approach of genome assembly [27] the authors generated 
multiple deletions (clusters from 5 to 24 genes) on the genome 
of Mycoplasma mycoides synthetic genome JCVI-syn 1.0 and 
marked each with a reporter protein (green fluorescent protein, 
GFP) on each insertion. Endeavors like this can only be 
achieved with full genome sequences. In this particular case, 
the complete nucleotide sequence (580,070 base pairs) of My-
coplasma genitalium [23], the smallest known genome of any 
free-living organism, was used to start building up large-scale 
molecules. The technique of genome transplantation was used 
to replace the full genome of a recipient cell and changing one 
bacterial species into another and to generate a new strain con-
trolled by a chemically synthetized genome [27,40]. In this 
genome, 470 predicted coding regions identified include genes 
required for DNA replication, transcription and translation, 
DNA repair, cellular transport, and energy metabolism.
Using the mating machinery of yeast, several deletions 
were generated at eight unique deletable regions of the ge-
nome, eliminating in a single step 91 genes and approximately 
10% of the original synthetic JCVI-syn 1.0 genome. With a 
second round of deletion and selection, the new strain con-
tained a deletion on seven of the eight targeted regions, repre-
senting 84 genes. This approach also considers the use of Tn 
insertions to characterize the content and targeting of several 
genes and determine their essentiality. The engineered ge-
nomes were analysed to look for growth defects, but most 
strains retained doubling times similar to the original strain, 
except for JCVI-syn1.0 ∆L strain and the multiple deletions 
strain JCVI-syn1.0 ∆1–6 ∆A ∆B ∆C ∆D ∆E ∆I ∆L ∆N, which 
had growth defects. Under the conditions tested, genetic inter-
actions of 91 genes were found. Despite predicted effects of 
the deletions on sugar metabolism, cell envelope and DNA 
metabolism, growth rates were unaffected by gene deletions in 
seven strains. All the data generated gave rise to the possibility 
of generating deletion strains or minimal genomes using rapid 
strategies and designing cells with the desired characteristics. 
The data also pointed out to the minimal set of genes required 
for life. Essential genes are important for biotechnology ap-
plications. In fact, the limiting steps for most metabolic reac-
tions can also be essential for cell physiology, and those genes, 
which are not present in the host’s genome, can also render 
specific targets for new drugs against pathogenic organisms. 
Essential genes for Mycoplasma had been previously as-
sessed by Glass and collaborators [30]. They carried out an 
extensive mutagenesis study in Mycoplasma genitalium to 
determine the number of essential genes required for lifeand 
was the milestone for generating the first chemically synthe-
sized bacterial genome [30,34]. Both studies showed that 
there is a minimal set of genes to make a completely func-
tional bacterial cell and that in vitro synthesis of a genome 
from scratch can give rise to a functional genome with the 
desired characteristics. In our opinion, this approach is com-
plementary to systems biology and all the ‘omics’. Instead of 
handling extensive amounts of data, it creates and puts to the 
test whole engineered genomes. The ultimate goal is to sim-
plify the created organisms with the minimal set of genes, 
given that, for M. genitalium, from 265 to 350 of the 480 pro-
tein-coding genes are essential under laboratory growth con-
ditions, including about 100 genes of unknown function.
Now we can start characterizing at a large scale the world 
of genes with unknown function, something relevant and dif-
ficult to approach. But even with the minimal set of genes, 
understanding the function is still out of reach, especially 
when mutants of genes without evident function also lack any 
phenotype. These studies also made clear that even if “read-
ing” DNA has been already achieved, understanding how to 
“write” DNA and make long functional “sentences” is still at 
an early stage of development. 
Other studies in organisms such as in yeast with the same 
aim indicated that 12% of its genome was essential and that 
almost 70% of the genomic disruptions gave no new pheno-
type [31]. Now the question arises for other organisms with 
more complex genomes. Estimates on Bacillus subtilis indi-
cate that only 9% of its genome is essential, rendering a non-
essential 562-kb genetic material from its total genome [36]. 
With the birth of synthetic biology, microbes can be assem-
bled for bits and render a desired phenotype or even behavior, 
thus providing a better understanding of how a cell works 
[20]. Other studies conducted in Escherichia coli have re-
vealed that, from the total 4288 genes it has, 303 genes were 
unable to be deleted from those 37 of unknown function [70]. 
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This study used a novel technique for interrupting single 
genes using PCR products containing a selective marker that 
had been used also in other organisms [14]. 
Research with microorganisms has the advantage of hav-
ing molecular tools for generating diverse mutants and ge-
netic engineering, a task that is more complicated on higher 
organisms. In humans, knockouts are off-limits, but we can 
learn from naturally occurring diseases. One recent example 
of gene mutation and deletion in humans that renders inactive 
genes can shed light on possible future research on the gen-
eral population for dispensable genes. Recently Sulem et al. 
identified deletions of up to 1000 autosomal genes from the 
genomes of normal human individuals. Thus, at least 1000 
genes can be eliminated without observing defects. As defined 
in the research paper, these are “healthy knockouts” [57]. 
From this concept, a novel field has arisen that looks for genes 
that, when they are missing, can confer a benefit, such as re-
sistance to certain diseases, including AIDS. The effect of a 
disease-related gene can be mimicked by blocking the normal 
gene’s protein the absence of that gene is known not to be a 
trheat for the host. Regarding health-associated organisms, 
scientists are trying to understand the role of diverse gene net-
works that are involved in virulence and pathogenesis. Using 
cumulative data and with the help of systems biology (i.e., an 
holistic approach to biology) the fundamental cellular pro-
cesses in organisms can be simulated [60] (Fig. 2).
All the data collected thus far from the minimal gene set or 
essential genes in diverse organisms can lead to a better un-
derstanding of cell basic functions and in a near future a whole 
picture of what is required to generate a fully functional living 
organism or at least make more accurate predictions on pro-
tein networks and the interactions within an organism. 
From the biotechnological point of view, this may be the 
future for all pharmaceutical advances and pipeline produc-
tion of different molecules, which must be expanded from E. 
coli, Mycoplasma and yeast due to ecological niche restric-
tions or environmental restrains. Synthetic biology can broad-
en our knowledge on organism’s basic functions and the regu-
lation of life processes using a bottom-up approach of engi-







Fig. 3. General overview of possible applications of synthetic biology for microbial and other organisms. Our understanding of life from the single 
cell to the population and multicellular levels.
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“Writing” DNA: engineering biological 
systems
Our ability to ‘read’ DNA is far better than that to ‘write’ it. 
Although the development of software and databases have 
made this task easier, most of the biological processes are not 
yet well understood. The first modest attempt to generate a syn-
thetic DNA fragment led to one of the most fundamental ad-
vances in molecular genetics, breaking the genetic code [1]. 
One impediment was related to costs and fidelity with DNA in 
vitro synthesis. The history of DNA synthesis has been bril-
liantly reviewed in [52], so we will focuse on its applications. 
This technology, which allowed sequencing and PCR, nowa-
days is used also to produce synthetic genes in a cost-effective 
manner or large-scale genome synthesis. There are major ad-
vances in large DNA synthesis with important improvements in 
fidelity, length and yield. The transition from column-based 
synthesis to array synthesis, allowed companies to offer more 
cost-effective, higher yields and fidelity on the desired se-
quence, also making less expensive to generate full open read-
ing frames (ORF) and with the desired codon usage for the 
proper host [36]. 
Higher fidelity synthesis either by PCR or de novo DNA 
synthesis is a major achievement for microbial and pathogen 
research. Both techniques allow to tackle the restrictions of 
construct design (which for certain applications can be trouble-
some) and assembly, gene expression and regulation, codon us-
age bypasses, transgene and vector creation, mutagenesis, pro-
tein engineering, and reporter protein adaptation for a particular 
host, creating new sequences with the desired codon usage for 
specific hosts among others [38]. One excellent example is the 
synthesis of nearly 44 Mb for knocking out with iRNA most 
human and mouse genes [12]. For protein studies, antimicro-
bial peptides or proteins and vaccine subunit preparation and 
purification, codon usage has proved to be a major hindrance to 
obtain high yields of recombinant proteins in many hosts, in 
particular for E. coli, which is a cost-effective host [5].
The motivation to review this subject was especially to en-
courage other researchers to explore synthetic biology as a 
powerful approach to complex problems. It is of particular in-
terest to our laboratories to improve existing tools for under-
standing the fundamental basis of pathogenesis in the parasitic 
protist Entamoeba histolytica. There are tools for manipulating 
this organism, but there are also limitations to generate mutants 
and versatile plasmid vectors or reporter genes. Synthetic biol-
ogy, however, can help to overcome these problems. We are 
also interested in the improvement of genetically encoded bio-
sensors to couple metabolite, metals, nanoparticles, toxins and 
other environmental or biomedical relevant molecules to sev-
eral outputs and easier to detect [48].
But, what does synthetic biology do? Using a broad defini-
tion, synthetic biology is in the quest to simplify our under-
standing of biological entities (viral, bacterial and eukaryal 
organisms) by constructing biochemical or genetic pathways 
both in vivo and in silico and building up computational mod-
els to simulate the behavior of those pathways with the ulti-
mate goal of testing them in the real world [65] (Fig. 3). Syn-
thetic biology also attempts to generate genetically recoded 
organisms or biological entities by using a design process 
more systematic and predictable and by analyzing models that 
use all the data available for that particular engineered process, 
robustness in the output of the designed organism, scalable to 
different niches or conditions, and ideally, more efficient than 
the wild type counterpart [65]. These criteria cover basically 
the necessities for applied genetic engineering with the easy 
approach of designing modules or parts to do specific tasks, 
which in a complete organism is still unpredictable at a large 
scale due to problems of interacting protein networks or en-
zyme cascades that are self-regulated or that interact with oth-
er pathways.
A major motivation for massive genome engineering is the 
applicability of modified microorganism that generates a prof-
it or can contribute to generate new biologically based pro-
cesses [66]. With the birth of synthetic biology, microbes can 
be assembled for bits and render a desired phenotype or even 
behavior, thus providing a better understanding of how a cell 
works. This approach, which is complementary to systems bi-
ology and all the ‘omics’, instead of handling extensive 
amounts of data, creates and puts to the test whole organisms 
with truly engineered parts and not using the traditional ran-
dom mutagenesis or directed evolution and selection approach 
[25]. Now we can build biological parts and genetic modules 
that are not found in nature or that are poorly characterized due 
to difficulties on growing the desired microorganism, with the 
purpose of generating fully functional genetic circuits that can 
modulate the behavior of cells and respond to specific stimuli. 
Synthetic biology shares many similarities with genetic engi-
neering principles such as minimality to avoid complex inter-
actions and futile cycles, modularity to improve interactions 
and sustain specificity, and controllability of a complete sys-
tem [16] (Figs. 1 and 2). Controllability of any genetic circuit 
is important to achieve the desired results, but also to prevent 
modified microorganisms from escaping from the lab (see 
"Potential misuse of the new technologies" Section). When 
working with pathogens difficult to handle and transport, an 
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alternative option might be inactivation and sequencing at the 
deployment site and revitalization in a laboratory for further 
scientific assessment [72] (see Section on “Potential misuse of 
the new technologies”).
The toolbox
Based on engineering principles and specialized syntax, Bio-
Bricks can overcome the troubles found when designing large 
molecules composed of different modules comprising regula-
tory, coding and terminator sequences to generate circuits or 
recombinant plasmid vectors [51]. Using wild type or de-
signed promoters, coding regions, terminators and reporter 
genes, we can integrate them to characterize cryptic genes or 
gene clusters, create new reporter plasmids and proteins, sim-
plifying maintaining reading frame with the coding regions 
and the assembly itself. This particular strategy is an assem-
bly method based on type II restriction enzymes, in which 
building blocks are assembled directionally by adding stan-
dardized flanking and complementary sequences that specify 
the orientation. The use of a reference syntax and access num-
bers, BioBrick parts sequence and properties are deposited in 
a specialized database [the Registry of Standars Biological 
Parts, http://parts.igem.org/Main_Page] available to the syn-
thetic biology community and can speed up the research 
world-wide. Using traditional restriction and ligation reac-
tions, assembly and joining together all the elements needed 
is easier when using in-house software to generate regulatory 
circuits with natural or artificially upgraded regulatory se-
quences according to the needs or aims.
Using modifications of the restriction enzymes for each 
BioBrick, the combinatorial capacity is sufficient for even con-
structing fragments of over 20 kb (such as the secondary me-
tabolite actinorhodin gene cluster from Streptomyces coelicol-
or) [43]. However, this strategy is time consuming and trouble-
some for joining multiple genes or DNA fragments using dif-
ferent joining sequences and finding the proper endonucleases 
to achieve such constructs. Moreover, mutations can arise at 
the overlapping Section. Protocols using modified versions of 
BioBrick methods can produce faster results using PCR-fusion 
techniques were each BioBrick part contains overlapping ends 
and can be used to fuse up to four individual modules. How-
ever, there are still some limitations regarding fidelity during 
synthesis and assembly success, especially when designing the 
overlapping regions [55]. Improvements on this technique led 
to the Golden Gate assembly method where subcloning of up 
to 9 different modules (as undigested plasmids) can be cloned 
into a recipient vector with the usage of type II restriction en-
zymes and it is done in one step in a single tube with a 90% 
efficiency, rendering several clones that can be analyzed to 
verify sequence and orientation of the fragments [19]. This 
strategy is useful to shuffle modules of different molecules to 
generate combinatorial versions of it and improve its character-
istics. It is especially useful to generate proteins with a desired 
activity or even for the production of vaccines in which epit-
opes can be screened for higher reactivity against anti-serum 
from patients. The generation of bigger constructs faces techni-
cal problems, including the lack of restriction enzymes to be 
used in a highly specific manner. Due to such problems, other 
techniques have been developed for both in vitro and in vivo 
assembly. The most prominent in vitro methods are PCR-based 
with overlapping 15 or more bases and require in vitro recom-
bination such as In-Fusion, SLIC and Gibson, which are more 
efficient for generating kilobase-sized fragments which led to 
the assembly of a fully functional synthetic bacterial genome 
and more recently the complete and engineered chromosome 
III of yeast synthesized stepwise [4,28,54]. With the possibility 
of synthesizing larger DNA molecules in vitro, the next logical 
step was to start the assembly of genes and genomes. Now the 
assembly of viral, bacterial and yeast chromosomes is possible. 
Before attempting the synthesis and assembly of large DNA 
molecules and facing the ethical implications of generating a 
fully functional organism, Smith and colleagues first assem-
bled the fX174 genome under strict ethical evaluation (see 
also "Potential misuse of the new technologies" Section) [56]. 
A serious limitation is the formation of multimer assembled 
molecules, for which a method has been recently proposed to 
avoid using linear fragment assembly and ligation, followed by 
in vivo cyclization after transforming recipient E. coli cells 
[32]. Methods used for generating synthetic chromosome III of 
yeast involved 750-bp modules and all the techniques previ-
ously described. In this experimnent, undergraduate students 
from the Build-A-Genome class at Johns Hopkins University 
were involved in generating the starting building blocks as part 
of a class project [4]. The cases of Mycoplasma and chromo-
some III from yeast synthetic molecules, in which the cells re-
mained viable and functional, set the foundations for more ag-
gressive engineering for gene function and protein network 
studies, as well for full organism engineering. The accurate 
assembly of large DNA fragments is still challenging and re-
quires refinement in order to generate fully functioning genes. 
Gene clusters must be done in vivo as described for Mycoplas-
ma, and yeast synthetic genome and chromosome III using 
overlapping fragments or pools of oligonucleotides, require 
yeast recombination machinery [26,32].
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Comprehension on essential genes is one step further into 
knowing new molecular targets for new drugs against patho-
gens (Fig. 3). To achieve this, extensive knowledge on each 
particular genome is necessary. With the discovery of en-
zymes capable of cleaving DNA at specific sequences, now 
this can be performed. 
TALEN (transcription activator-like effectors) or CRISPR 
(clustered regularly interspaced short palindromic repeats)/
Cas both can be used nowadays to edit specific targets in any 
genome by designing either the zinc finger specificity in 
TALEN zinc finger nucleases ZFNs) or the RNA guide mol-
ecule that directs enzyme specificity [8,29]. TALEN technol-
ogy relays on ZFNs that are fairly specific to triplet sequences 
and can cleave specific regions on any given genome and can 
be engineered (in combination with the techniques described 
so far) to target cleavage to a desired sequence [29]. The 
CRISPR/Cas system in bacteria is a prokaryotic adaptive de-
fense barrier against foreign DNA and is the most basic form 
of adaptive defense mechanisms against foreign DNA inside 
the genome that can be active as a phage or inactive [29]. One 
spectacular feature is that this system learns to recognize the 
self from the non-self DNA and it can adapt to new molecules 
invading the host’s genome. This novel system has been 
adapted in numerous ways to visualize (by only binding to 
target sequence), edit and control genes and gene expression 
in several organisms [29].
One of the limitations of this enzymatic system is that the 
isolated and characterized CRISPR/Cas enzymes have high 
molecular weight, making large constructs which are limited 
to transfection on eukaryotic cells. More recently, a smaller 
version of Cas9 has been isolated with the same genome edit-
ing properties and can be used more extensively than the pre-
viously isolated enzymes [50]. With all the current tools avail-
able we can envision that new tools can be generated. As al-
ready mentioned, many microorganisms have different G+C 
contents, codon usage and different cellular properties that 
can make certain studies more difficult. In such cases, syn-
thetic biology offers techniques than can overcome such com-
plications. 
Plasmids for different purposes can be easily generated 
and adapted to each application, like expression plasmids de-
signed with the regulatory elements necessary to render prop-
er expression using limited information (for organisms which 
genome sequence is still underway or just partial sequences 
are available), codon usage bypass for gene function studies 
and reporter protein applications. Other examples are plas-
mids for the generation of genetic circuits with specific func-
tions that can share light on gene function or protein network 
interactions, and codon usage expansion and incorporation of 
artificial amino acids for structural studies, or when protein 
expression is limited in alternate hosts due to specific post-
translational modifications that are under study, such as gly-
cosylation. In our laboratories we do research to discover 
novel virulence factors and determinants in parasitic protists. 
We now explore the generation of novel tools using approach-
es such as the one reported by Wegner and colleagues, who 
described the generation of a fully functional vector for Plas-
modium falciparum by using the Gibson assembly method 
[64]. This kind of studies motivated us to expand our comfort 
zone and move into synthetic biology.
 
Applications for microbiology
With the increasing antibiotic resistance in pathogens, the 
quest for new molecules that can attend the needs of patients 
requires novel approaches (Figs. 2 and 3). Nichols and col-
leagues have developed a high-throughput platform, the iCh-
ip, to grow and isolate bacteria [42]. This device allows to 
grow bacteria directly on soil avoiding the problems of grow-
ing microorganisms in the laboratory. Using this technology, 
a new antibiotic was isolated (teixobactin) without observing 
resistant mutants of the bacteria tested [42]. This technique 
offers the possibility of identifying and characterizing new 
antibiotics as well as new organisms for NGS. Coupling both 
strategies, synthetic cells can produce the desired secondary 
metabolites and open a new field for developing novel phar-
maceuticals. A good example is reviewed by Nikel et al., who 
point out the applications that can be generated using syn-
thetic biology applied to pseudomonads also taking the ad-
vantage of using the ecological niche of each organism iso-
lated and characterized. If synthetic biology can be used to 
adapt organisms to grow in the lab, in its corresponding eco-
logical niche and control them, the applications are endless 
for understanding the biology of of microorganisms, in par-
ticular molecular, cellular and environmental-ecological char-
acteristics [47]. Molecular tools can be used also to study 
gene function and gene relationships. In the case of patho-
genic protists, there are certain limitations regarding genetic 
manipulation. We have tools for transfecting protists and a 
limited set of vectors, but this is now not a limiting factor. 
King et al. have described several novel genes involved in 
phagocytosis in Entamoeba histolytica that were discovered 
by using a genome-wide overexpression screening or the use 
of CRISPR/Cas system to generate single or multiple mutants 
in Trypanosoma cruzi or Toxoplasma gondii [37,49].
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Finally, epidemics and the role of emerging diseases with 
host shifts that can render more virulent strains (such as Ebola 
or SARS) are a growing concerned worldwide. In the previ-
ous sections we have provided some examples of the power of 
NGS to address major epidemiologic problems including the 
role of pathogen distribution even at city scale. One limitation 
for vaccine production is the expression of proteins for vac-
cine research and mass production. This powerful technique 
can solve this problem by rapidly synthesizing several epit-
opes from fully sequenced virus and testing for their effec-
tiveness as vaccines. One example is the use of hemagglutinin 
and neuraminidase of influenza virus, optimized for their ex-
pression in MDCK cells. With such studies the response to 
epidemics can be improved and even optimized for local out-
breaks with a particular mutant strain using sequence data 
from patients during an outbreak [17]. This kind of technolo-
gy can also be used at large scale for other purposes, for ex-
ample to produce full-length viral particles or several anti-
genic proteins from pathogens with genomic differential G+C 
content or that are difficult to grow in the laboratory. This 
strategy can be applied also in veterinary medicine. This kind 
of technology can speed up the trajectory from development, 
production and commercialization of both biopharmaceuti-
cals and traditional antibiotics; the end molecules are the 
same, just the process of generation changes. Synthetic biol-
ogy is useful not only to improve the yields of natural prod-
ucts of producing strains but also for chemical structure diver-
sification to generate new active analogues.
As above mentioned, the microbiome plays a major 
role in health and disease. New sequencing techniques have 
revealed that humans are a holobiont, and their microorgan-
isms can modulate many biological functions. Some recent 
research efforts have been made to achieve the power of all 
living organisms inside the body to promote immune boost, 
vaccine delivery systems, diagnostics, biosensors for different 
diseases and keeping a stable environment or promote the 
growth of beneficial organisms [68]. Genome editing strate-
gies may have also therapeutic applications. One challenging 
task is to safely remove viral particles from any given ge-
nome, which under these terms seems science fiction. How-
ever, the genome editing capabilities of the CRISPR/Cas sys-
tem theoretically might reduce the total viral genomes inte-
grated to the genome in any integrating viral infection.
Using NGS on several infected cells we can design the 
specificity of either TALEN nucleases or Cas9 enzymes to 
edit and delete viral sequences, in the same manner that bac-
teria do it. This was achieved in human cells infected with 
HIV [42]. The application of the CRISPR/Cas technology to 
reduce the total viral pool in cells infected with HIV is still at 
an early stage, but the some results so far obtained are promis-
ing.
Potential misuse of synthetic biology
With all the technology at hand and the resources to explore 
new boundaries, and despite of the oncoming benefits for sci-
ence, and biotechnology in particular, many citizens including 
scientific community are wondering how dangerous this 
emerging field of biology can be. Definitely the understanding 
of virus, bacteria and protists that affect humans can increase 
with technologies such as the described above. However, how 
ethical is to synthesize a fully functional and potentially dan-
gerous organism in order to study it? 
With the announcement of the synthetic Mycoplasma ge-
nome, during a press conference, Dr. Hamilton Smith was 
asked about the potential application of this technology as a 
bioweapon. His answer was: “We could make the small pox 
genome”. At that moment, Dr. Venter tried to soften his col-
league’s statement by saying that DNA is not infective by it-
self, and Dr. Smith insisted that “But you [Dr. Venter] and I 
[Dr. Smith] have discussed ways to get around that”. Dr. 
Smith finally said “I probably shouldn’t have said that, huh?” 
[63]. The only limits to this technology are set by imagina-
tion. We can sinthesize many things, but science is strictly 
regulated and requires highly trained personnel to achieve the 
desired goals. For example, when Smith and colleagues at-
tempte to create the synthetic fX174 phage [56], it took al-
most a year to set up a bioethics committee to review the pro-
posal and deliberate that “[researchers are] taking a reason-
able scientific approach to an important biological question” 
[9]. The biological question at hand can lead to important 
findings regarding the basis for life and perhaps one day also 
to understand what is necessary for life to flourish elsewhere. 
The tools generated with the fX174 lead Venter’s group to a 
10-year quest to achieve a fully functional chemically synthe-
sized genome [27]. The “bottom-up” approach to generate 
genomes can lead to several unethical applications as envi-
sioned by many since databases contain the genomic sequence 
of all kinds of organisms including pathogenic and potentially 
turned into weapons, but can this be real? 
A major concern is the introduction of synthetic organisms 
that may be harmful to others or to the ecological niche. Syn-
thetic organisms should be contained to laboratory or con-
trolled conditions. Mandell et al. [44] reported the generation 
of two different modified strains of E. coli so that they exhib-
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ited metabolic dependence on non-standard amino acids and 
demonstrated that they were impaired of bypassing this bio-
control by horizontal gene transfer or mutagenesis [44]. 
This kind of research brings us closer to generate fully 
synthetic organisms that could be used on controlled environ-
ments and to rewire organisms to synthesize biomolecules 
with the desired function without the obvious dangers of re-
leasing an uncontrolled organism into the environment. The 
synthetic biology community is aware of those dangers and 
works to provide more safety features to genetically modified 
organisms. It is true that infective viral particles, bacteria or 
other pathogens could be synthezided as bioweapons. How-
ever, the technical challenge is too great to consider it a con-
stant treat. Synthetic biology techniques are more beneficial to 
understand the pathogenesis process than to do harm. One ex-
cellent example is the ability to obtain and characterize viruses 
that are not cultivable or can share light on the structure and 
infectiveness of virus no longer present and only their genom-
ic sequence is available and renders it fully functional [61]. 
Concluding remarks
Synthetic biology offers powerful, elegant techniquea to re-
duce genome sizes, generate new molecules or tools and ex-
pand our knowledge on the essential genes of bacteria and 
yeast and maybe in a near future for any given organism. 
Technology based on synthetic biology can provide not only 
tools, but extensive new knowledge of gene function and in 
particular of essential genes. In our opinion, the fields that can 
take the most advantage from this technology are: biotechnol-
ogy, medicine, cellular and molecular biology, and astrobiol-
ogy. In the case of astrobiology (Fig. 3), we envision that, 
once the basic rules for life are understood here on Earth, life 
in other conditions can be tested on varying conditions and 
even at extreme environments such as the International Space 
Station. Synthetic organisms can be a powerful tool to study 
the requirements for alien conditions and hypotheses can be 
tested based using this experimental approach. 
Genome engineering can lead to several and highly sig-
nificant biotechnological advances. In other areas we expect 
that knowledge on protein machinery assembly and interac-
tions can one day answer the most fundamental aspects of life 
and in particular what is required to generate functional gene 
and protein networks (Fig. 2). Thereof we can approach not 
only microbes in general, but pathogens or hosts, providing 
basis to advance our understanding on the molecular and cel-
lular basis for disease. 
All these achievements require computational and molec-
ular biology skills that our youth should develop and get in-
volved as with the yeast chromosome III synthesis. With stan-
dardized methods of assembly and the design of particular 
modules that can be interchanged, the International Geneti-
cally Engineered Machine (iGEM) Foundation has estab-
lished an international competition to propel youth into the 
field of synthetic biology [http://igem.org/Main_Page]. Soon 
genetic circuits and synthetic organisms will be part of basic 
molecular genetics courses at colleges and high schools. 
Can this new technology be a potential hazard? As with 
any new technology, it is possible to be used for warfare and 
biological or organism-based terrorism, but the technical and 
scientific infrastructure needed renders this possibility to the 
minimum as for many other technologies. For that reason it is 
important to emphasize that scientists must avoid the modifi-
cation of microorganisms for bioweapons production [3]. We 
envision more benefits than treats to synthetic biology and we 
encourage the scientific community dedicated to study micro-
organisms and pathogens to turn their eyesight to this new and 
exciting new field of molecular biology. It can expand the 
knowledge on microorganisms, neither harmful for the envi-
ronment nor for living beings. Studies on pathogenicity mech-
anisms, for instance, will benefit from the responsible manip-
ulation and ethical use of modified microorganisms. 
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